Head of R&D - Integrated Decision Support (IDS)

Location: Erlangen, Germany
Job Type: Full-Time
Employer: Siemens Healthineers
Do you want to help create the future of healthcare? Our name, Siemens Healthineers, was selected to honor our people who dedicate their energy and passion to this cause. It reflects their pioneering spirit combined with our long history of engineering in the ever-evolving healthcare industry.

We offer you a flexible and dynamic environment with opportunities to go beyond your comfort zone in order to grow personally and professionally. Sound interesting?

Then come and join our global team as Head (f/m/d) of R&D - Integrated Decision Support (IDS) to lead the global R&D program of the AI-Pathway Companion in order to optimize care pathways with an intelligent decision support system aimed at facilitating diagnosis and therapeutic decisions along disease-specific pathways.

Your tasks and responsibilities

  • You are responsible for leading the R&D organization spanning across Europe (Germany & Slovakia), USA, and Asia (India), reporting to the head of the AI-pathway companion product line
  • You will work in an innovation program in the field of Integrated Decision Support in healthcare, enabling the team to drive prototypes to products, owning pre-development to product lifecycle management (PLM) processes
  • You are responsible for the international project coordination of our teams with associated technology, development and clinical collaboration partners distributed around the world
  • You are responsible for development projects’ target achievements, along with the team’s Lean coaching and iterative planning (yearly, quarterly, monthly) within the Lean setup
  • You lead the regular preparation and transparent communication of the project status and mitigation plans to all stakeholders involved (including heads of business line/area)
  • You identify risks and issues and set up measures (including enablement of the teams) to resolve them
  • Your tasks include scaling of project team, resource and budget planning, steering of project plans as well as the control of the overall targets of the projects

To find out more about the specific business, have a look at AI-Pathway Companion.

Your qualifications and experience

  • You hold a university degree in computer science or a related engineering discipline
  • You have many years of experience in software development projects and you have proven record working in an agile/lean oriented project organization with internationally distributed teams
  • You have many years of experience in a leadership role, ideally in a global context and/or matrix organization
  • You have experience in the healthcare sector and respective regulatory environment (e.g. FDA 21CFR820 QSR, ISO 13485, 62304)

Your attributes and skills

  • You have very good command of English, both spoken and written; additional language skills such as German are welcome
  • You are result oriented, assertive, and able to analyze and improve your team’s working skills
  • You have extensive knowledge in project management methods and tools (backlog management, planning, controlling, risk management)
  • You have advanced moderation and presentation skills
  • You exhibit strong interpersonal skills especially in a cross-cultural environment
  • You are available travel Internationally when needed (approx. 10%)

Apply for this job

About Siemens Healthineers AG

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalising healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care to patients. In fiscal 2020, which ended on September 30, 2020, Siemens Healthineers, which has approximately 54,000 employees worldwide, generated revenue of €14.5 billion and adjusted EBIT of €2.2 billion.

Post your job offer now to start hiring the best digital health talent! For further information, please contact us.

Most Popular Now

The Future of Medicine is Data

At the 2023 Annual J.P. Morgan Healthcare Conference, Owkin Co-founder and CEO Thomas Clozel, MD will outline how data is the future of medicine - from the development of new...

Study Surveys Landscape of Apps Built on…

A study led by Regenstrief Institute Research Scientist Titus K. Schleyer, DMD, PhD, is among the first to survey the current landscape of FHIR® apps, providing a snapshot of how...

New Computer Program 'Learns' to Identif…

Genetic mutations cause hundreds of unsolved and untreatable disorders. Among them, DNA mutations in a small percentage of cells, called mosaic mutations, are extremely difficult to detect because they exist...

Applications Open for SpinLab Accelerato…

The start-up accelerator supports entrepreneurial and innovative teams that want to grow sustainably and successfully scale their business model. With a strong hands-on mentality and a lot of passion, the...

Bayer to Accelerate Drug Discovery with …

Bayer AG and Google Cloud today announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-developed accelerators designed to run...

Allscripts Announces Corporate Name Chan…

Allscripts Healthcare Solutions, Inc. announced that, effective January 1, 2023, it has changed its name to Veradigm Inc. (NASDAQ: MDRX). Allscripts had been transitioning its solutions to the Veradigm brand...

220M€ Investment in Testing and Experime…

To make the EU the place where AI excellence thrives from the lab to the market, the European Union is setting up world-class Testing and Experimentation Facilities (TEFs) for AI. Together...

AI Tool Developed to Predict Risk of Lun…

Lung cancer is the leading cause of cancer death in the United States and around the world. Low-dose chest computed tomography (LDCT) is recommended to screen people between 50 and...

Artificial Nerve Cells - Almost Like Bio…

Researchers at Linköping University (LiU), Sweden, have created an artificial organic neuron that closely mimics the characteristics of biological nerve cells. This artificial neuron can stimulate natural nerves, making it...

Bayer Acquires Blackford Analysis Ltd. B…

Bayer announced the acquisition of the global strategic imaging AI platform and solutions provider Blackford Analysis Ltd. The acquisition is part of Bayer's strategy to drive innovation in radiology, including...

For Shared Decision-Making, Telemedicine…

Telemedicine may be just as effective as in-person visits when it comes to shared decision-making and communication for patients undergoing a first-time surgery consultation, according to a study published as...

Veradigm Announces Strategic Investment …

Veradigm Inc. (NASDAQ: MDRX), formerly Allscripts Healthcare Solutions, Inc., announced an investment in Holmusk, a global behavioral health real-world evidence and data analytics company, as part of Holmusk's $45 million...